Tekla Life Sciences Inves... (HQL)
NYSE: HQL
· Real-Time Price · USD
16.46
0.25 (1.54%)
At close: Oct 15, 2025, 3:59 PM
16.45
-0.06%
After-hours: Oct 15, 2025, 06:21 PM EDT
Tekla Life Sciences Investors Balance Sheet Statement
Financials in USD. Fiscal
year is
October - September.
Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
Period Ending | Mar 31, 2025 | Sep 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | n/a | n/a | n/a | 477.00 | 822.00 | 445.00 | 292.4K | 990.00 | 159.00 |
Short-Term Investments | 12.16M | n/a | n/a | 15.24M | 11.98M | 32.94M | 22.42M | 17.17M | 1.05M |
Cash & Short-Term Investments | 12.16M | n/a | n/a | 15.24M | 822.00 | 445.00 | 292.4K | 990.00 | 159.00 |
Receivables | 6.39M | 231.11K | 112.96K | 5.04M | 12.82K | 623.47K | 3.1M | 150.34K | 5.41K |
Accounts Receivables | n/a | 231.11K | 112.96K | 5.04M | n/a | n/a | 3.1M | 143.67K | n/a |
Other Receivables | 6.39M | n/a | n/a | n/a | 12.82K | 623.47K | n/a | n/a | 5.41K |
Inventory | n/a | n/a | n/a | n/a | 11.99M | 33.57M | 25.82M | n/a | 1.05M |
Prepaid Expenses | n/a | 41.53K | 49.99K | -15.24M | 33.19K | 25.18K | 31.95K | 26.3K | 43.81K |
Other Current Assets | -18.55M | 8.97K | 8.97K | n/a | 2.65M | 11.09M | 13.94M | 8.46M | 1.05M |
Total Current Assets | n/a | 281.61K | 171.92K | 5.05M | 13.64K | 623.92K | 3.39M | 144.66K | 5.57K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Intangible Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 460.3M | 429.95M | 397.53M | 432.64M | 414.08M | 444.99M | 534.01M | 503.2M |
Tax Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | 13.9M | 11.83M | n/a | -432.64M | -414.08M | -444.99M | -534.01M | -503.2M |
Total Long-Term Assets | n/a | 474.2M | 441.78M | 397.53M | 432.64M | 414.08M | 444.99M | 534.01M | 503.2M |
Other Assets | 411.34M | -13.9M | n/a | 26.28K | 33.38K | 25.36K | 34.16K | 32.97K | 124.13K |
Total Assets | 411.34M | 460.58M | 441.95M | 402.6M | 432.69M | 414.73M | 448.41M | 534.19M | 503.33M |
Total Payables | n/a | 1.79K | 229.3K | n/a | 9.33M | 5.1M | 3.54M | 8.7M | 44.08K |
Account Payables | n/a | 1.79K | 229.3K | n/a | 12.82K | 5.1M | 3.54M | 150.34K | 44.08K |
Other Payables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Accrued Expenses | n/a | 836.01K | 650.61K | n/a | 711.17K | n/a | n/a | 703.12K | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Current Capital Lease Obligations | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Tax Payables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 5.09M | -5.15M | n/a | n/a |
Other Current Liabilities | n/a | 50.81K | n/a | n/a | -10.04M | -5.1M | -3.54M | -9.4M | -44.08K |
Total Current Liabilities | n/a | 888.61K | 879.91K | n/a | 10.04M | 5.1M | 3.54M | 10.75M | 44.08K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Non-Current Capital Lease Obligations | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Non-Current Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 209.84K | 1.34M | n/a |
Non-Current Deferred Tax Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 886.82K | 650.61K | 666.96K | n/a | n/a | -209.84K | -1.34M | n/a |
Total Long-Term Liabilities | n/a | 886.82K | 650.61K | 666.96K | 10.04M | 5.1M | 3.54M | 9.4M | 649.63K |
Other Liabilities | 15.4M | n/a | n/a | n/a | -10.04M | 6.62M | 5.85M | -9.4M | -44.08K |
Capital Lease Obligations | n/a | n/a | n/a | n/a | n/a | n/a | 209.84K | 1.34M | n/a |
Total Liabilities | 15.4M | 888.61K | 879.91K | 666.96K | 10.04M | 16.82M | 12.94M | 10.75M | 649.63K |
Treasury Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Preferred Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 288.72K | 280.61K | 273.5K | 267.91K | 262.12K | 256.8K | 251.44K | 246.68K | 242.79K |
Retained Earnings | -30.52M | 44.13M | 30.19M | -1.48M | 26.83M | 9.55M | 54.34M | 150.7M | 138.19M |
Additional Paid-In Capital | 426.17M | 415.29M | 410.6M | 403.15M | 395.55M | 388.1M | 380.89M | 372.49M | 364.25M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Stockholders Equity | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 395.94M | 459.69M | 441.07M | 401.93M | 422.65M | 397.9M | 435.47M | 523.44M | 502.68M |
Total Equity | 395.94M | 459.69M | 441.07M | 401.93M | 422.65M | 397.9M | 435.47M | 523.44M | 502.68M |
Minority Interest | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Liabilities & Equity | 411.34M | 460.58M | 441.95M | 402.6M | 432.69M | 414.73M | 448.41M | 534.19M | 503.33M |
Total Investments | 12.16M | 460.3M | 429.95M | 397.53M | 432.64M | 414.08M | 444.99M | 534.01M | 503.2M |
Total Debt | n/a | n/a | n/a | n/a | 9.33K | 11.09K | 209.84K | 1.34M | n/a |
Net Debt | n/a | n/a | 13.84M | -477 | 8.51K | 10.65K | -82.56K | 1.34M | -159 |
Book Value | 395.94M | 459.69M | 441.07M | 401.93M | 422.65M | 397.9M | 435.47M | 523.44M | 502.68M |
Book Value Per Share | 13.71 | 15.98 | 16.13 | 15.00 | 16.12 | 15.49 | 17.32 | 21.22 | 20.70 |
Source: Financial Modeling Prep. Financial Sources.